FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019885 [Registered on: 26/06/2019] Trial Registered Prospectively
Last Modified On: 25/06/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   TO EVALUATE THE EFFICACY OF SHIGRU-NIRGUNDI GHAN VATI IN POSTOPERATIVE PAIN MANAGEMENT  
Scientific Title of Study   A COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF SHIGRU-NIRGUNDI GHAN VATI IN POSTOPERATIVE PAIN W.S.R. TO ANAL FISSURE  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  SHRADDHA SAHU 
Designation  M.S. SCHOLAR 
Affiliation  NATIONAL INSTITUTE OF AYURVEDA JAIPUR RAJASTHAN  
Address  NATIONAL INSTITUTE OF AYURVEDA JAIPUR RAJASTHAN AMER ROAD MADHAV VILAS JAIPUR 302002
shalya tantra department opd no- 28 national institute of ayurveda jaipur.
Jaipur
RAJASTHAN
302002
India 
Phone  8839929943  
Fax    
Email  shraddhasahu21791@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR ASHOK KUMAR 
Designation  ASSOCIATE PROFESSOR 
Affiliation  NATIONAL INSTITUTE OF AYURVEDA JAIPPUR,RAJASTHAN 
Address  NATIONAL INSTITUTE OF AYURVEDA JAIPUR RAJASTHAN AMER ROAD MADHAV VILAS JAIPUR
shalya tantra department opd no- 28 national institute of ayurveda jaipur.
Jaipur
RAJASTHAN
302002
India 
Phone  9649180572  
Fax    
Email  ashok_hp1976@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DR ASHOK KUMAR 
Designation  ASSOCIATE PROFESSOR 
Affiliation  NATIONAL INSTITUTE OF AYURVEDA JAIPPUR,RAJASTHAN 
Address  NATIONAL INSTITUTE OF AYURVEDA JAIPUR RAJASTHAN AMER ROAD MADHAV VILAS JAIPUR
shalya tantra department opd no- 28 national institute of ayurveda jaipur.
Jaipur
RAJASTHAN
302002
India 
Phone  9649180572  
Fax    
Email  ashok_hp1976@yahoo.com  
 
Source of Monetary or Material Support  
NATIONAL INSTITUTE OF AYURVEDA PHARMACY JAIPUR RAJASTHAN MADHAV VILAS JAIPUR 302002 
 
Primary Sponsor  
Name  NATIONAL INSTITUTE OF AYURVEDA JAIPUR RAJASTHAN 
Address  NATIONAL INSTITUTE OF AYURVEDA JAIPUR RAJASTHAN AMER ROAD MADHAV VILAS JAIPUR 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
SHRADDHA SAHU  NATIONAL INSTITUTE OF AYURVEDA HOSPITAL JAIPUR RAJASTHAN   SHALYA TANTRA DEPARTMENT OPD NO-28
Jaipur
RAJASTHAN 
8839929943

shraddhasahu21791@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE NATIONAL INSTITUTE OF AYURVEDA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K626||Ulcer of anus and rectum,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  SHIGRU - NIRGUNDI GHAN VATI   Group II – SHIGRU - NIRGUNDI GHAN VATI – 500 mg 8 hourly with water. Group III – SHIGRU - NIRGUNDI GHAN VATI – 1 gm 8 hourly with water. 
Comparator Agent  SHIGRU - NIRGUNDI GHAN VATI DICLOFENAC SODIUM 50MG  DOSE- Group I – Diclofenac Sodium – 50 mg with water Group II – SHIGRU - NIRGUNDI GHAN VATI – 500 mg with water Group III – SHIGRU - NIRGUNDI GHAN VATI – 1 gm with water. FREQUENCY- TDS(Thrice a day) Route- orally  
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients undergoing surgical intervention for Parikartika (Anal Fissure) of age between 16 – 60 years irrespective of gender, religion etc.
2. Patients not requiring to be kept nil via mouth in postoperative period.
3. Willing to participate in the study.
 
 
ExclusionCriteria 
Details  1. Patient not willing to participate in the trial.
2. Patient below age of 16 and more than 60yrs.
3. Please specify –antihypertensive,lipid lower medicines,thyroid disorders.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
TO GET RELIEVE ON POSTOPERATIVE PAIN  3 DAYS 
 
Secondary Outcome  
Outcome  TimePoints 
PAIN RELIEF.  3 DAYS 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/09/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="3" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Pain is the most important symptom in clinical practice which compels an individual to seek medical advice. When someone undergoes any surgical intervention whether minor or major, first thing which comes in the mind of that individual is that it will involve pain after the procedure, which is very true. There is little doubt that surgical intervention whether minor or major will involve some sort of pain, intensity of which may vary from minor discomfort to severe pain. Pain can be classified variously viz. acute and chronic, mild moderate or severe. Patients undergoing surgical procedures suffer postoperative pain which is obvious. Postoperative pain management is an important part in surgical practice which is often underestimated. Data suggest that 80% of patients experience postoperative pain1. 11 to 20 percent of patients experience severe pain postoperatively2. 

 
Close